Familial hyperaldosteronism type 1 in pregnancy
2009; Wiley; Volume: 39; Issue: 2 Linguagem: Inglês
10.1111/j.1445-5994.2008.01869.x
ISSN1445-5994
AutoresEmma Hamilton, Christopher J. O’Callaghan, Richard M. O’Brien, Michael Stowasser, Richard D. Gordon, Jeffrey D. Zajac, Mathis Grossmann,
Tópico(s)Apelin-related biomedical research
ResumoInternal Medicine JournalVolume 39, Issue 2 p. 135-136 Familial hyperaldosteronism type 1 in pregnancy E. Hamilton, E. Hamilton Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this authorC. O'Callaghan, C. O'Callaghan Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this authorR. M. O'Brien, R. M. O'Brien Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this authorM. Stowasser, M. Stowasser Endocrine Hypertension Research Centre, University of Queensland School of Medicine Greenslopes and Princess Alexandra Hospital, Brisbane, Queensland, AustraliaSearch for more papers by this authorR. Gordon, R. Gordon Endocrine Hypertension Research Centre, University of Queensland School of Medicine Greenslopes and Princess Alexandra Hospital, Brisbane, Queensland, AustraliaSearch for more papers by this authorJ. Zajac, J. Zajac Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this authorM Grossmann, M Grossmann Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this author E. Hamilton, E. Hamilton Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this authorC. O'Callaghan, C. O'Callaghan Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this authorR. M. O'Brien, R. M. O'Brien Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this authorM. Stowasser, M. Stowasser Endocrine Hypertension Research Centre, University of Queensland School of Medicine Greenslopes and Princess Alexandra Hospital, Brisbane, Queensland, AustraliaSearch for more papers by this authorR. Gordon, R. Gordon Endocrine Hypertension Research Centre, University of Queensland School of Medicine Greenslopes and Princess Alexandra Hospital, Brisbane, Queensland, AustraliaSearch for more papers by this authorJ. Zajac, J. Zajac Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this authorM Grossmann, M Grossmann Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VictoriaSearch for more papers by this author First published: 31 March 2009 https://doi.org/10.1111/j.1445-5994.2008.01869.xCitations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Stowasser M, Gordon RD. Familial hyperaldosteronism. J Steroid Biochem Mol Biol 2001; 78: 215– 29. 2 Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S et al. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355: 262– 5. 3 Wyckoff JA, Seely EW, Hurwitz S, Anderson BF, Lifton RP, Dluhy RG. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 2000; 35: 668– 72. 4 Oelkers WKH. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996; 61: 166– 71. 5 Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000; 289: 119– 23. 6 Crown A, Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol 2005; 63: 483– 92. Citing Literature Volume39, Issue2February 2009Pages 135-136 ReferencesRelatedInformation
Referência(s)